Akari Therapeutics Plc (AKTX)

0.2711 +0.01 (+3.91%) USD  |  NASDAQ  |  Jan 22, 14:42
More

Akari Therapeutics Non-Operating Interest Expense (Quarterly)

Non-Operating Interest Expense (Quarterly) Chart

View Non-Operating Interest Expense (Quarterly) for AKTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Non-Operating Interest Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Non-Operating Interest Expense (Quarterly) Range, Past 5 Years

View Non-Operating Interest Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Non-Operating Interest Expense (Quarterly) Benchmarks

View Non-Operating Interest Expense (Quarterly) Benchmarks
Start Trial
DBV Technologies SA Upgrade
Cellectis SA Upgrade
Biodexa Pharmaceuticals Plc --
NuCana Plc Upgrade
Autolus Therapeutics Plc Upgrade